Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Soleno Therapeutics Inc
SLNO | US
52.72
USD-0.11
-0.21%
SLNO | US
Loading StockChartView...
About Soleno Therapeutics Inc
Sector
Healthcare
Industry
Diagnostics & Research
Earnings date
30/06/2024
As of date
24/04/2026
Close
52.72
Open
52.88
High
52.88
Low
52.70
Soleno Therapeutics Inc. a clinical-stage biopharmaceutical company focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets a once-daily oral tablet which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia Inc. and changed its name to Soleno Therapeutics Inc. in May 2017. Soleno Therapeutics Inc. was incorporated in 1999 and is based in Redwood City California.
View LessSLNO | US
Risk
119.3
Sharpe
-0.46
Luna's Score
45/100
Recommendation
Sell
Luna says (SLNO | US)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
What's not Working
High 6-Month Volatility (>65%)
Midcap (2B - 10B USD)
Low negative Beta, possible Low Liquidity (< -0.4)
High Short percentage (> 15%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
2.9%1 month
119.3%3 months
86.6%6 months
81.1%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
7.41
Debt to equity
0.00
Debt to assets
0.00
Ent. to EBITDA
0.02
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-66.53M
MarketCap
2.05B
MarketCap(USD)
2.05B
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-44.62
Short ratio
10.39
Short perc.
20.70
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
0.40
Range1M
23.41
Range3M
23.41
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.49
Price X volume
171.28M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.02 | 12.67 | Cheaper |
| Ent. to Revenue | - | 44.00 | - |
| PE Ratio | - | 40.09 | - |
| Price to Book | 7.41 | 77.50 | Cheaper |
| Dividend Yield | - | 1.18 | - |
| Std. Deviation (3M) | 86.64 | 59.59 | Riskier |
| Debt to Equity | 0.00 | -14.36 | Expensive |
| Debt to Assets | 0.00 | 0.34 | Cheaper |
| Market Cap | 2.05B | 13.71B | Emerging |
